CSF2 and pulmonary alveolar proteinosis: Finally, nose-only delivery of rSIV.F/HN encoding granulocyte-macrophage colony-stimulating factor (GM-CSF) led to sufficient lung levels of this therapeutic protein to correct disease biomarkers in a mouse model of pulmonary alveolar proteinosis.